title: Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
authors.forename: J M
authors.initials: JM
authors.lastname: Achard
authors.forename: L
authors.initials: L
authors.lastname: Leborgne
authors.forename: C
authors.initials: C
authors.lastname: Tribouilloy
authors.forename: J C
authors.initials: JC
authors.lastname: Aldigier
authors.forename: A
authors.initials: A
authors.lastname: Fournier
mesh_terms: D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005838:Genotype; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D000077583:Quinapril; D044005:Tetrahydroisoquinolines
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril